These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17214363)

  • 1. Prognostic significance of serum antibodies to HPV-16 L1 virus-like particles in patients with invasive cervical cancer.
    Skiba D; Mehlhorn G; Fasching PA; Beckmann MW; Ackermann S
    Anticancer Res; 2006; 26(6C):4921-6. PubMed ID: 17214363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer.
    Heim K; Widschwendter A; Pirschner G; Wieland U; Awerkiew S; Christensen ND; Bergant A; Marth C; Höpfl R
    Am J Obstet Gynecol; 2002 Apr; 186(4):705-11. PubMed ID: 11967495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.
    Monroy-García A; Gómez-Lim MA; Weiss-Steider B; la Rosa GP; Hernández-Montes J; Pérez-Saldaña K; Tapia-Guerrero YS; Toledo-Guzmán ME; Santiago-Osorio E; Sanchez-Peña HI; Mora-García Mde L
    Virol J; 2011 Feb; 8():59. PubMed ID: 21306638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
    J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of HPV-DNA and anti-HPV antibodies in women from Girardot, Colombia.
    Leon S; Sánchez R; Patarroyo MA; Camargo M; Mejia A; Urquiza M; Patarroyo ME
    Sex Transm Dis; 2009 May; 36(5):290-6. PubMed ID: 19295467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of antibody response to HPV 16 and HPV 18 antigens in Tunisian patients.
    Achour M; Kahla S; Zeghal D; Kochbati L; Mongi M; Zouari F; Oueslati R
    Viral Immunol; 2009 Feb; 22(1):7-16. PubMed ID: 19210223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions.
    Mehlhorn G; Hautmann SK; Koch MC; Strehl JD; Hartmann A; Hilfrich R; Beckmann MW; Griesser H
    Anticancer Res; 2014 Sep; 34(9):5127-32. PubMed ID: 25202103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus 16 and 18 L1 serology in Korean women with high-grade cervical intraepithelial neoplasia and cervical cancer.
    Jeong NH; Woo MK; Lee NW; Hur SJ; Choi KS; Kim HJ
    Arch Pharm Res; 2009 Jul; 32(7):1013-8. PubMed ID: 19641882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response for L1, E6 and E7 HPV 16 and HPV 18 antigens in Tunisian women with cervical cancer and controls.
    Achour M; Zeghal D; Kochbati L; Kahla S; Zouari F; Maalej M; Oueslati R
    J Immunoassay Immunochem; 2008; 29(3):266-80. PubMed ID: 18569375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response for L1, E6, E7 HPV 16, and HPV 18 antigens in Tunisian women with cervical cancer.
    Achour M; Zeghal D; Kochbati L; Kahla S; Zouari F; Maâlej M; Oueslati R
    J Immunoassay Immunochem; 2009; 30(1):82-96. PubMed ID: 19117204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological study in Tunisian cervical cancer patients.
    Achour M; Kochbati L; Zeghal D; Kahla S; Maalej M; Zouari F; Oueslati R
    Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.
    Luxton JC; Rose RC; Coletart T; Wilson P; Shepherd PS
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():917-23. PubMed ID: 9129666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Gallee MP; Hart AA; Müller M; Trimbos JB; Helmerhorst TJ
    Cancer; 1994 Oct; 74(8):2307-13. PubMed ID: 7922982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
    J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer.
    Viladiu P; Bosch FX; Castellsagué X; Muñoz N; Escribà JM; Hamsíkova E; Hofmannova V; Guerrero E; Izquierdo A; Navarro C; Moreo P; Izarzugaza I; Ascunce N; Gili M; Muñoz MT; Tafur L; Shah KV; Vonka V
    J Clin Oncol; 1997 Feb; 15(2):610-9. PubMed ID: 9053484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific serologic studies with a novel authentic HPV antigen (virus-like particles) for HPV-6 antibodies in gynecologic patient samples].
    Heim K; Christensen ND; Höpfl R; Wartusch B; Zeimet A; Larcher C; Ruth N; Bergant A; Pirschner G; Dierich MP
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():25-31. PubMed ID: 8672922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-vaccination with adeno-associated virus vectors encoding human papillomavirus 16 L1 proteins and adenovirus encoding murine GM-CSF can elicit strong and prolonged neutralizing antibody.
    Liu DW; Chang JL; Tsao YP; Huang CW; Kuo SW; Chen SL
    Int J Cancer; 2005 Jan; 113(1):93-100. PubMed ID: 15386434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
    Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
    Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors.
    Nieto K; Kern A; Leuchs B; Gissmann L; Müller M; Kleinschmidt JA
    Antivir Ther; 2009; 14(8):1125-37. PubMed ID: 20032542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.
    Pedersen C; Petaja T; Strauss G; Rumke HC; Poder A; Richardus JH; Spiessens B; Descamps D; Hardt K; Lehtinen M; Dubin G;
    J Adolesc Health; 2007 Jun; 40(6):564-71. PubMed ID: 17531764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.